PMID- 33763116 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210326 IS - 1664-8021 (Print) IS - 1664-8021 (Electronic) IS - 1664-8021 (Linking) VI - 12 DP - 2021 TI - Targeted RNA-Based Oxford Nanopore Sequencing for Typing 12 Classical HLA Genes. PG - 635601 LID - 10.3389/fgene.2021.635601 [doi] LID - 635601 AB - Identification of human leukocyte antigen (HLA) alleles from next-generation sequencing (NGS) data is challenging because of the high polymorphism and mosaic nature of HLA genes. Owing to the complex nature of HLA genes and consequent challenges in allele assignment, Oxford Nanopore Technologies' (ONT) single-molecule sequencing technology has been of great interest due to its fitness for sequencing long reads. In addition to the read length, ONT's advantages are its portability and possibility for a rapid real-time sequencing, which enables a simultaneous data analysis. Here, we describe a targeted RNA-based method for HLA typing using ONT sequencing and SeqNext-HLA SeqPilot software (JSI Medical Systems GmbH). Twelve classical HLA genes were enriched from cDNA of 50 individuals, barcoded, pooled, and sequenced in 10 MinION R9.4 SpotON flow cell runs producing over 30,000 reads per sample. Using barcoded 2D reads, SeqPilot assigned HLA alleles to two-field typing resolution or higher with the average read depth of 1750x. Sequence analysis resulted in 99-100% accuracy at low-resolution level (one-field) and in 74-100% accuracy at high-resolution level (two-field) with the expected alleles. There are still some limitations with ONT RNA sequencing, such as noisy reads, homopolymer errors, and the lack of robust algorithms, which interfere with confident allele assignment. These issues need to be inspected carefully in the future to improve the allele call rates. Nevertheless, here we show that sequencing of multiplexed cDNA amplicon libraries on ONT MinION can produce accurate high-resolution typing results of 12 classical HLA loci. For HLA research, ONT RNA sequencing is a promising method due to its capability to sequence full-length HLA transcripts. In addition to HLA genotyping, the technique could also be applied for simultaneous expression analysis. CI - Copyright (c) 2021 Johansson, Koskela, Yohannes, Partanen and Saavalainen. FAU - Johansson, Tiira AU - Johansson T AD - Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. AD - Finnish Red Cross Blood Service, Helsinki, Finland. FAU - Koskela, Satu AU - Koskela S AD - Finnish Red Cross Blood Service, Helsinki, Finland. FAU - Yohannes, Dawit A AU - Yohannes DA AD - Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. FAU - Partanen, Jukka AU - Partanen J AD - Finnish Red Cross Blood Service, Helsinki, Finland. FAU - Saavalainen, Paivi AU - Saavalainen P AD - Translational Immunology Research Program and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. AD - Finnish Red Cross Blood Service, Helsinki, Finland. LA - eng PT - Journal Article DEP - 20210304 PL - Switzerland TA - Front Genet JT - Frontiers in genetics JID - 101560621 PMC - PMC7982845 OTO - NOTNLM OT - HLA genotyping OT - MinION OT - RNA sequencing OT - human leukocyte antigen OT - nanopore sequencing COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/03/26 06:00 MHDA- 2021/03/26 06:01 PMCR- 2021/03/04 CRDT- 2021/03/25 06:27 PHST- 2020/11/30 00:00 [received] PHST- 2021/02/11 00:00 [accepted] PHST- 2021/03/25 06:27 [entrez] PHST- 2021/03/26 06:00 [pubmed] PHST- 2021/03/26 06:01 [medline] PHST- 2021/03/04 00:00 [pmc-release] AID - 10.3389/fgene.2021.635601 [doi] PST - epublish SO - Front Genet. 2021 Mar 4;12:635601. doi: 10.3389/fgene.2021.635601. eCollection 2021.